Analysts Expect Acadia Healthcare Company Inc (NASDAQ:ACHC) Will Announce Quarterly Sales of $784.15 Million

Wall Street brokerages forecast that Acadia Healthcare Company Inc (NASDAQ:ACHC) will report sales of $784.15 million for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have made estimates for Acadia Healthcare’s earnings, with estimates ranging from $773.20 million to $827.90 million. Acadia Healthcare posted sales of $743.55 million in the same quarter last year, which suggests a positive year over year growth rate of 5.5%. The business is scheduled to announce its next earnings results on Thursday, February 27th.

According to Zacks, analysts expect that Acadia Healthcare will report full year sales of $3.10 billion for the current fiscal year, with estimates ranging from $3.10 billion to $3.11 billion. For the next year, analysts anticipate that the business will report sales of $3.27 billion, with estimates ranging from $3.21 billion to $3.39 billion. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Tuesday, November 5th. The company reported $0.52 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.55 by ($0.03). The business had revenue of $777.25 million during the quarter, compared to analyst estimates of $790.39 million. Acadia Healthcare had a negative net margin of 6.88% and a positive return on equity of 7.31%. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same quarter last year, the business posted $0.55 earnings per share.

Several research firms have recently issued reports on ACHC. UBS Group boosted their target price on Acadia Healthcare from $29.00 to $34.00 and gave the stock a “neutral” rating in a research report on Friday, September 20th. Raymond James lowered Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $45.00 target price for the company. in a research report on Wednesday, July 31st. Jefferies Financial Group set a $40.00 target price on Acadia Healthcare and gave the stock a “buy” rating in a research report on Thursday, October 10th. Zacks Investment Research lowered Acadia Healthcare from a “hold” rating to a “sell” rating and set a $31.00 target price for the company. in a research report on Wednesday, August 7th. Finally, ValuEngine lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday. Two analysts have rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $36.00.

ACHC stock traded up $0.02 during midday trading on Monday, reaching $32.02. The stock had a trading volume of 872,500 shares, compared to its average volume of 857,153. The firm has a market cap of $2.79 billion, a price-to-earnings ratio of 14.29, a PEG ratio of 1.48 and a beta of 0.66. Acadia Healthcare has a twelve month low of $24.27 and a twelve month high of $35.40. The business has a fifty day simple moving average of $30.54 and a two-hundred day simple moving average of $31.28. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 1.49.

In other news, CEO Debra K. Osteen bought 20,000 shares of the business’s stock in a transaction on Thursday, September 5th. The shares were purchased at an average price of $26.53 per share, for a total transaction of $530,600.00. Following the purchase, the chief executive officer now owns 117,178 shares of the company’s stock, valued at approximately $3,108,732.34. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 2.60% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. MUFG Americas Holdings Corp grew its stake in shares of Acadia Healthcare by 127.4% in the 2nd quarter. MUFG Americas Holdings Corp now owns 1,294 shares of the company’s stock worth $45,000 after buying an additional 725 shares during the last quarter. Panagora Asset Management Inc. grew its stake in shares of Acadia Healthcare by 84.1% in the 2nd quarter. Panagora Asset Management Inc. now owns 3,940 shares of the company’s stock worth $138,000 after buying an additional 1,800 shares during the last quarter. Advisor Group Inc. grew its stake in shares of Acadia Healthcare by 27.1% in the 2nd quarter. Advisor Group Inc. now owns 4,208 shares of the company’s stock worth $146,000 after buying an additional 896 shares during the last quarter. HighTower Advisors LLC purchased a new stake in shares of Acadia Healthcare in the 2nd quarter worth approximately $205,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Acadia Healthcare by 25.4% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,421 shares of the company’s stock worth $224,000 after buying an additional 1,300 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.

Featured Story: What is meant by holder of record?

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.